UroGen Pharma Ltd. earnings per share and revenue

URGN earnings per share for the last quarter are -0.55 USD whereas the estimation was -0.82 USD which accounts for 32.69% surprise. Company revenue for the same period amounts to 25.20 M USD despite the estimated figure of 24.20 M USD. Estimated earnings per share for the next quarter are -0.72 USD, and revenue is expected to reach 26.13 M USD. Also watch annual changes over time to get a bigger picture of URGN earnings per share and revenue dynamics.